Re. Inder et al., Role of cytochrome P4502E1 in retinol's attenuation of carbon tetrachloride-induced hepatotoxicity in the Swiss Webster mouse, TOXICOL SCI, 52(1), 1999, pp. 130-139
In the mouse, retinol administration attenuates carbon tetrachloride (CCl4)
-induced hepatic injury. We have investigated the role of cytochrome P4502E
1 (CYP2E1) in this interaction. Male Swiss Webster mice were administered r
etinol (75 mg/kg/d) or vehicle for 3 days prior to CCI4 (30 mu l/kg, ip). H
epatotoxicity produced by CCI4 was assessed by plasma alanine aminotransfer
ase (ALT) activity and light microscopy (ALT activity of 1391 +/- 430 vs. 2
74 +/- 92 IU/L for vehicle + CCl4 and retinol + CCl4 treatments respectivel
y, p < 0.05). Retinol's attenuation of liver injury was maintained when CCl
4 was administered 48 h after the conclusion of the retinol pretreatment. A
niline hydroxylation activity, an indicator of CYP2E1 catalytic activity, d
etermined on day 4 was 33.8% of untreated control in vehicle + CCI4 treatme
nts while the retinol + CCl4 treatment group was 94.2% of untreated control
. Additionally, CYP2E1 immunoreactive protein was 78% lower in vehicle + CC
l4 vs. retinol + CCl4 treatment groups. Attenuation of potentiated hepatoto
xicity was also observed when CYP2E1 was induced by acetone (ALT activity o
f 3119 +/- 1066 vs. 247 +/- 77 IU/L for vehicle and retinol treatments resp
ectively, p < 0.05). In the mouse, retinol itself does not alter constituti
ve or inducible CYP2E1 expression. However, in combination with CCl4 retino
l does reduce the amount of CCl4 bioactivated to its toxic metabolite. We c
onclude that retinol attenuates CCl4-induced hepatotoxicity by causing a de
crease in CCl4 bioactivation but does not cause a decrease in CYP2E1 expres
sion.